Underutilization of palliative care services in the liver transplant population. by Kathpalia, Priya et al.
UCSF
UC San Francisco Previously Published Works
Title
Underutilization of palliative care services in the liver transplant population.
Permalink
https://escholarship.org/uc/item/3wt2s8r2
Journal
World journal of transplantation, 6(3)
ISSN
2220-3230
Authors
Kathpalia, Priya
Smith, Alexander
Lai, Jennifer C
Publication Date
2016-09-01
DOI
10.5500/wjt.v6.i3.594
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Priya Kathpalia, Alexander Smith, Jennifer C Lai
Priya Kathpalia, Jennifer C Lai, Division of Gastroenterology 
and Hepatology, UCSF, San Francisco, CA 94143, United States
Alexander Smith, Division of Geriatrics, UCSF, San Francisco, 
CA 94143, United States
Author contributions: All authors contributed to the manuscript. 
Institutional review board statement: This study was 
reviewed and approved by the UCSF Institutional Review Board. 
Informed consent statement: This study was reviewed and 
approved by the UCSF Institutional Review Board.
Conflict-of-interest statement: There are no disclosures or 
conflicts-of-interest involving any of the study authors. 
Open-Access: This article is an open-access article which was 
selected by an in-house editor and fully peer-reviewed by external 
reviewers. It is distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this 
work non-commercially, and license their derivative works on 
different terms, provided the original work is properly cited and 
the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/
Manuscript source: Unsolicited manuscript
Correspondence to: Jennifer C Lai, MD, MBA, Division of 
Gastroenterology and Hepatology, UCSF, 513 Parnassus Avenue, 
UCSF Box 0538, San Francisco, CA 94143, 
United States. jennifer.lai@ucsf.edu
Telephone: +1-415-4766422
Fax: +1-415-4760659
Received: March 22, 2016
Peer-review started: March 23, 2016
First decision: May 13, 2016
Revised: June 28, 2016
Accepted: July 14, 2016
Article in press: July 18, 2016
Published online: September 24, 2016
Abstract
AIM
To evaluate use of palliative care services in patients 
with end-stage liver disease who do not have access to 
liver transplant.
METHODS
Evaluated were end-stage liver disease patients who 
were removed from the liver transplant wait-list or 
died prior to transplant at a single transplant center 
over a 2-year period. Those who were removed due to 
noncompliance or ultimately transplanted elsewhere 
were excluded from this study. Patient characteristics 
associated with palliative care consultation were ass-
essed using logistic regression analysis.
RESULTS
Six hundred and eighty-three patients were listed for 
liver transplant in 2013-2014 with 107 (16%) dying (n  
= 62) or removed for clinical decompensation prior to 
liver transplant (n  = 45): Median age was 58 years, 
and the majority were male (66%), Caucasian (53%), 
had Child C cirrhosis (61%) or hepatocellular carcinoma 
(52%). The palliative care team was consulted in 
only 18 of the 107 patients (17%) who died or were 
removed, 89% of which occurred as inpatients. Half of 
these consultations occurred within 72 h of death. In 
univariable analysis, patients of younger age, white 
race, and higher end-stage liver disease scores at 
time of listing and delisting were more likely to receive 
palliative care services. Only younger age [Odds ratio 
(OR) = 0.92; P  = 0.02] and Caucasian race (OR = 
4.90; P  = 0.02) were still associated with integration of 
palliative care services through multivariable analysis.
CONCLUSION 
Palliative care services are grossly underutilized in older, 
non-white patients with cirrhosis on the liver transplant 
wait-list. We encourage early integration of these ser-
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Core tip: Without liver transplant, patients with cirrhosis 
have 50% mortality at 5 years; these patients represent 
a population that would benefit from palliative care 
services. Palliative care services are grossly underutilized 
in older, non-white patients with cirrhosis on the liver 
transplant wait-list. We encourage early integration 
of these services into clinical decision-making in the 
transplant population, with further studies aimed at 
understanding barriers to consultation.
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INTRODUCTION
Decompensated cirrhosis is characterized by ascites, 
hepatic encephalopathy, and variceal bleeding. Mortality 
is high with 50% death rate due to complications 
of cirrhosis within five years[1,2]. In addition to these 
medical complications, patients with decompensated 
cirrhosis experience a large symptomatic burden 
including debilitating fatigue, muscle wasting, anorexia, 
and intractable pruritus. Self-reported quality of life is 
poor in cirrhotics; in one study, 38% of elderly patients 
with cirrhosis had difficulty in independently completing 
at least one daily living activity including dressing, 
walking few steps, or bathing while 10% had impaired 
integral activities of daily living (i.e., managing money, 
cooking, grocery shopping)[3-5]. Their physical symptoms, 
inability to independently care for themselves, and 
knowledge of their terminal disease often erodes their 
emotional and psychological well-being. 
While it is clear that liver transplantation is essen-
tially the only known cure for complications of end-
stage liver disease, the ability to receive a transplant 
can be unpredictable: One in five individuals awaiting 
liver transplantation will die on the waitlist[6]. While the 
process of listing individuals for liver transplantation 
is highly structured through formal medical, surgical, 
social, and psychological evaluations, there is no 
standard of care for the process to transition those 
who are deemed too sick for liver transplantation to 
comfort care. We aimed to evaluate current utilization of 
palliative care services in liver transplant candidates who 
did not survive to liver transplant and understand which 
patient characteristics are associated with palliative care 
consultation in this population. 
MATERIALS AND METHODS
All adult cirrhotic patients who were newly listed for liver 
transplant at a single, large volume United States liver 
transplant center from January 1, 2013 to December 
31, 2014 and died prior to transplant or were delisted 
for being too ill for transplant were included in this 
study. We excluded patients delisted due to inadequate 
social support, medical non-adherence, active substance 
abuse, or those who were transplanted at another 
center. 
Patient demographics (age, gender, ethnicity, lan-
guage spoken), etiology of liver disease, Model for 
End-Stage Liver Disease (MELD) score at time of 
transplant listing, and education level were received 
from the United Network for Organ Sharing and Organ 
Procurement and Transplantation Network registries. 
Patients’ MELD at delisting or death, Child Pugh Score 
at time of removal, presence of hepatocellular cancer 
(HCC), and insurance type were collected through 
review of the electronic health record. Details on the 
palliative care consultations were also manually revie-
wed from the electronic medical records.
Descriptive statistics were computed for all conti-
nuous variables (age at listing, candidate MELD lab 
score when being listed for transplant) including means, 
medians, and interquartile ranges. The rank sum test 
was used for these continuous variables. Pearson’s χ2 
testing was used for the categorical values (candidate 
gender, ethnicity, highest education level, and diagno-
sis) to further compare the baseline characteristics of 
patients removed from the waiting list vs those who 
remained active. We employed univariable logistic regre-
ssion to identify factors associated with palliative care 
consultation with a P value cut-off of 0.10. These factors 
were then evaluated for inclusion in the final multivari­
able logistic regression model using backwards step-
wise elimination, using a P value cut-off of 0.05. 
This study was approved by the Institutional Review 
Board of UCSF. Stata, version 12 (Stata Corp., College 
Station, TX) was used for statistical analyses.
RESULTS
There were 683 patients placed on the liver transplant 
list in 2013-2014, of which 107 (16%) ultimately dying 
(n = 62) or removed for clinical decompensation prior to 
liver transplant (n = 45). Median age was 58 years and 
majority (66%) was male. Majority of the patients who 
died or were de-listed were white (53.3%), followed 
by Hispanic (22.4%), Asian (12.1%), Black (9.3%), 
and other (2.8%). The etiology of cirrhosis was alcohol 
(11%), hepatitis C (41%), alcohol and hepatitis C 
(20%), and various other etiologies (30%). Majority of 
these patients had Child-Pugh Class C cirrhosis (60.7%) 
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while 52% of these patients had HCC. In terms of 
education level, 93.5% had a college degree or less 
(Table 1).
Of these 107 patients who were delisted or died 
while awaiting transplant, 18 (17%) received a palliative 
care consult in the 2-year period, of which 89% occurred 
as inpatients. The median number of days (interquartile 
range) from palliative care consultation to death was 4 
(1-11) d; half of these consultations occurred within 72 
h of death and 17% on the same day as death (Figure 
1). Reasons for palliative care consultation included 
aiding in transitioning to hospice in 78% of patients, 
goals of care without transition to comfort care in 11%, 
and symptom management including refractory ascites, 
pruritus, and pain in the remaining 11%. Even from the 
26 patients with ESLD who were delisted for advanced 
HCC, just 12% had palliative care consultation.
Patient characteristics associated with palliative care 
consultation in univariate analysis included younger age 
(OR = 0.92; P < 0.01), white race (OR = 3.74; P = 
0.03), and higher MELD at listing (OR = 1.06; P = 0.02) 
and at delisting (OR = 1.05; P = 0.01). Subsequent 
multivariable analysis revealed only younger age (OR = 
0.92; P = 0.02) and white race (OR = 4.90; P = 0.02) 
remained associated with utilization of palliative care 
services (Table 2).
DISCUSSION
According to the World Health Organization, palliative 
care “improves the quality of life of patients and 
their families facing the problem associated with life-
threatening illness, through the prevention and relief of 
suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, 
physical, psychosocial, and spiritual”[7]. For patients with 
end-stage liver disease, early integration of palliative 
care into their routine medical care is particularly crucial 
to understanding patients’ preferences for the end 
of life, as progressive hepatic encephalopathy often 
leads to impaired decision-making. Those on the liver 
transplant list, however, represent a unique sub-group 
of patients with a “terminal” condition - by virtue of 
having end-stage liver disease - but await the promise 
of a cure through liver transplantation. In this setting, 
palliative care, which traditionally has been considered 
only for those “at the end of life”, may be perceived - by 
both the patient and providers alike - as unnecessary 
and unwelcome[8-11].
Indeed, we observed very low utilization of palliative 
care services among liver transplant candidates who 
ultimately died or were delisted for being too sick for 
liver transplant. Among the 17% of these patients who 
received palliative care services, half of the consultations 
occurred within 72 h of death and one in five occurred 
on the day of death, hardly enough time to develop 
rapport and aid both patients and their caregivers in 
the transition to supportive care at the end of life[12,13]. 
Importantly, we identified two factors - younger age 
and non-Hispanic white race - that were associated with 
palliative care consultation. This finding confirms a prior 
study evaluating barriers to palliative care among older 
adults that demonstrated that a terminal diagnosis in 
an elderly patient often is considered an “expectation” 
rather than a shock compared to that in a younger 
patient; it is also possible that younger patients at the 
end of life have more support networks/caretakers at 
this stage that advocate for improved quality of life[14,15]. 
Cultural and language barriers likely contribute to under-
utilization of palliative care services in the non-white 
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n  = 107
  Age at listing, yr   58 (53-63)
  Male sex 71 (66%)
  Ethnicity
     White    57 (53.3%)
     Hispanic    24 (22.4%)
     Asian    13 (12.1%)
     Black  10 (9.3%)
     Other    3 (2.8%)
  MELD at time of listing   16 (12-23)
  Etiology of cirrhosis
     Alcohol related 12 (11%)
     Hepatitis C 44 (41%)
     Alcohol + hepatitis C 21 (20%)
     Other 30 (28%)
  Child-pugh score at de-listing  
     A 16 (15%)
     B    26 (24.3%)
     C    65 (60.7%)
  HCC 56 (52%)
  Education level
     College degree or less   100 (93.5%)
     Graduate level degree    7 (6.5%)
Table 1  Baseline characteristics of 107 patients who died or 
were delisted for being too sick for transplant
MELD: Model for end-stage liver disease; HCC: Hepatocellular cancer.
683 patients listed 
for transplant
107 (16%) patients 
died/delisted 
18 (17%) palliative 
care consultations
16 (89%) occurred in 
inpatient setting
9 (50%) occurred 
≤ 3 d of death
3 (17%) occurred on
 same day of death
Figure 1  Palliative care consultations in patients who died or were 
delisted over a 24-mo period.
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transplant listing process. Baumann et al[17] confirmed 
that early palliative care utilization in patients listed for 
transplantation led to improved symptom management 
and well-being in this population.
While this study represents a critical first step 
towards developing interdisciplinary programs directed 
at providing palliative care to liver transplant candidates, 
future studies should focus on understanding barriers to 
early integration of palliative care in the liver transplant 
population among all ages and ethnicities, in both 
the inpatient and outpatient setting. In addition, in a 
prospective study, patient-centered outcomes can be 
obtained in efforts to show the direct impact of palliative 
care involvement on the physical and psychosocial 
well being of these patients. Ultimately the goal should 
be to facilitate collaboration and, perhaps, even co-
management between transplant and palliative care 
providers for the care of these complex patients - even 
when the intention to treat is curative - to improve 
the quality of care and quality of life for patients with 
cirrhosis awaiting liver transplantation.
COMMENTS
Background
Patients with end stage liver disease have 50% 5-year mortality due to 
complications of cirrhosis and experience a large symptomatic burden including 
debilitating fatigue, muscle wasting, anorexia, and intractable pruritus. While 
it is clear that liver transplantation is essentially the only known cure for 
complications of end-stage liver disease, the ability to receive a transplant 
can be unpredictable. In patients who do not have access to liver transplant, 
palliative care services may aid in quality of life of patients and caretakers alike. 
Research frontiers
Though the process of listing individuals for liver transplantation is highly 
structured, there is no standard of care for the process to transition those who 
are deemed too sick for liver transplantation to comfort care. Current utilization of 
palliative care services in liver transplant candidates who did not survive to liver 
transplant is not largely understood. 
population. 
In addition, we find it interesting that more than 
three-fourths of palliative care consultations in our 
population were to assist with transition to comfort care 
and just 11% were for aid in symptom management. 
This depicts how transplant clinicians view palliative 
care, as a mode to help make patients comfortable 
at the end of life, but not to facilitate goals of care 
discussions or to help relieve pain and suffering in a 
patient population with a terminal condition without 
transplantation. We recognize the need for integration 
of palliative care and transplant hepatology teams in 
efforts to provide comprehensive care for our patients 
to meet their physical and psychosocial needs even 
when actively listed for liver transplantation. 
We acknowledge that this study is limited by a 
relatively small sample size; however, it represents the 
entire eligible population at our liver transplant center 
during the study period, so is an unselected group. 
Another limitation is that we only evaluated those who 
died or were delisted rather than all patients on the liver 
transplant list. This was intentional, as we first wanted 
to evaluate the uptake of palliative care among those 
for whom death was certain.
Despite these limitations, this study represents 
one of the largest to date to evaluate palliative care 
consultation in the liver transplant population. Poonja 
et al[16] reported their experience in the liver transplant 
population at the University of Alberta and noted 
that of the 102 patients removed from the waitlist 
or declined over a 5 year period, only 10% were 
referred to palliative care despite high levels of pain, 
nausea, and depression. As patients with ESLD have 
high burden of symptoms, we advocate for increased 
utilization of palliative care services - for both symptom 
management and discussions regarding goals of care 
- and integration of such services early in the liver 
  Factor Univariable analysis Multivariable analysis 
OR (95%CI) P  value OR (95%CI) P  value
  Age, per year 0.92 (0.87-0.98) < 0.01 0.92 (0.87-0.98) 0.02
  Male sex 0.76 (0.27-2.16) 0.61 - -
  White race   3.74 (1.14-12.26) 0.03 4.90 (1.30-18.30) 0.02
  MELD at listing 1.06 (1.01-1.12) 0.02 1.00 (0.97-1.10) 0.39
  MELD at delisting 1.05 (1.00-1.10) 0.01 1.00 (0.97-1.10) 0.34
  Etiology of liver disease
     Alcohol related Reference Reference
     Hepatitis C 0.95 (0.17-5.28) 0.95 - -
     Alcohol + hepatitis C 1.56 (0.25-9.65) 0.63
     Other 0.77 (0.12-4.88) 0.78
  Child-pugh score at delisting 
     A Reference Reference
     B   0.60 (0.03-10.30) 0.73 - -
     C   4.90 (0.60-40.10) 0.14
  HCC 0.89 (0.32-2.46) 0.83 - -
  College or lower level of education (vs graduate level) 1.23 (0.14-10.9) 0.85 - -
  Private insurance (vs government) 0.70 (0.25-1.97) 0.50 - -
  English language 0.93 (0.24-3.65) 0.92 - -
Table 2  Factors associated with palliative care consultation, univariable and multivariable logistic regression analysis
MELD: Model for end-stage liver disease; HCC: Hepatocellular cancer.
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Innovations and breakthroughs 
Authors aimed to understand the use of palliative care services in patients with 
end-stage liver disease who do not have access to liver transplant over a 2-year 
period and a large volume center. Palliative care services were consulted in less 
than 20% of patients who were died or removed from the transplant list, majority 
of which occurred while patients were already hospitalized. In univariable 
analysis, patients of younger age, white race, and higher model for end-stage 
liver disease (MELD) scores at time of listing and delisting were more likely to 
receive palliative care services. Only younger age and Caucasian race were 
still associated with integration of palliative care services through multivariable 
analysis. The authors recognize that palliative care services are grossly 
underutilized in patients who are not deemed transplant candidates. 
Applications
While this study represents a critical first step towards developing interdisciplinary 
programs directed at providing palliative care to liver transplant candidates, 
future studies should focus on understanding barriers to early integration of 
palliative care in the liver transplant population. In addition, in a prospective 
study, patient-centered outcomes can be obtained to show the direct impact of 
palliative care involvement on the physical and psychosocial well being of these 
patients. Ultimately the goal should be to facilitate collaboration and, perhaps, 
even co-management between transplant and palliative care providers for the 
care of these complex patients - even when the intention to treat is curative - to 
improve the quality of care and quality of life for patients with cirrhosis awaiting 
liver transplantation.
Terminology
Palliative care services encompass more than aiding in transitioning to comfort 
care and assisting in goals of care discussions, and can be particularly helpful in 
symptom management, even in patients who are not terminally ill. The laboratory 
based MELD score accounts for patients’ bilirubin, international normalized ratio 
(INR), and creatinine levels and was calculated both at time of transplant listing 
and delisting. The child pugh score entails a combination of laboratory (bilirubin, 
albumin, INR) and clinical (presence of ascites, encephalopathy) factors; though 
it was originally used to predict mortality in cirrhotics at the time of surgery, if can 
also aid in understanding the severity of liver disease. 
Peer-review
This is an integral single center retrospective study that aims to shed light on the 
need for integration of palliative care into the liver transplant population, even 
when the intent to treat is curative, in efforts to improve their quality of life. 
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